[go: up one dir, main page]

MX2010004388A - Formulaciones de hormona paratiroidea y usos de las mismas. - Google Patents

Formulaciones de hormona paratiroidea y usos de las mismas.

Info

Publication number
MX2010004388A
MX2010004388A MX2010004388A MX2010004388A MX2010004388A MX 2010004388 A MX2010004388 A MX 2010004388A MX 2010004388 A MX2010004388 A MX 2010004388A MX 2010004388 A MX2010004388 A MX 2010004388A MX 2010004388 A MX2010004388 A MX 2010004388A
Authority
MX
Mexico
Prior art keywords
pth
parathyroid hormone
formulations
hormone formulations
stable
Prior art date
Application number
MX2010004388A
Other languages
English (en)
Inventor
Dorte Loer Linderoth
Lars Lindegaard Hansen
Original Assignee
Nycomed Danmark Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Danmark Aps filed Critical Nycomed Danmark Aps
Publication of MX2010004388A publication Critical patent/MX2010004388A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

En la presente, se proporcionan formulaciones estables de PTH que pueden administrarse a sujetos animales o humanos. En una modalidad, las formulaciones de PTH descritas en la presente se encuentran en la forma de formulaciones de solución estables que comprenden PTH, metionina, por lo menos un tensioactivo de Poloxámero y un agente regulador fisiológicamente aceptable. En la presente también se describen métodos para generar y utilizar las formulaciones de PTH descritas en la presente.
MX2010004388A 2007-10-26 2008-10-27 Formulaciones de hormona paratiroidea y usos de las mismas. MX2010004388A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US99606107P 2007-10-26 2007-10-26
EP07021017A EP2052736A1 (en) 2007-10-26 2007-10-26 Parathyroid hormone formulations und uses thereof
PCT/EP2008/009069 WO2009053106A1 (en) 2007-10-26 2008-10-27 Parathyroid hormone formulations and uses thereof

Publications (1)

Publication Number Publication Date
MX2010004388A true MX2010004388A (es) 2010-08-10

Family

ID=39146901

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010004388A MX2010004388A (es) 2007-10-26 2008-10-27 Formulaciones de hormona paratiroidea y usos de las mismas.

Country Status (14)

Country Link
EP (2) EP2052736A1 (es)
AT (1) ATE501725T1 (es)
CY (1) CY1112106T1 (es)
DE (1) DE602008005643D1 (es)
DK (1) DK2219665T3 (es)
ES (1) ES2363272T3 (es)
HR (1) HRP20110444T1 (es)
MX (1) MX2010004388A (es)
PL (1) PL2219665T3 (es)
PT (1) PT2219665E (es)
RU (1) RU2467762C2 (es)
SI (1) SI2219665T1 (es)
WO (1) WO2009053106A1 (es)
ZA (1) ZA201002812B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2833571A1 (en) * 2011-04-22 2012-10-26 Radius Health, Inc. Method of drug delivery for pth, pthrp and related peptides
KR102512178B1 (ko) * 2011-05-18 2023-03-20 메더리스 다이어비티즈, 엘엘씨 개선된 펩티드 제약
CA2857502C (en) 2011-11-30 2019-08-13 3M Innovative Properties Company Microneedle device including a peptide therapeutic agent and an amino acid and methods of making and using the same
WO2014027281A1 (en) * 2012-08-13 2014-02-20 Koninklijke Philips N.V. Use of antioxidants in methods and means for detection of target molecules in a blood sample
SI3122426T1 (sl) 2014-03-28 2023-04-28 Duke University Zdravljenje raka dojk z uporabo selektivnih modulatorjev estrogenskih receptorjev
IL255189B2 (en) 2015-04-29 2024-04-01 Radius Pharmaceuticals Inc A combination of rad1901 and a cdk4/6 inhibitor for use in treating cancer
GB201602880D0 (en) 2016-02-18 2016-04-06 Ge Healthcare Uk Ltd Method and composition for biomolecule stabilization
EP4470613A3 (en) 2016-03-01 2025-03-12 Ascendis Pharma Bone Diseases A/S Pth prodrugs
NZ751969A (en) 2016-09-29 2023-04-28 Ascendis Pharma Bone Diseases As Dosage regimen for a controlled-release pth compound
EP4218795A3 (en) 2016-09-29 2023-08-30 Ascendis Pharma Bone Diseases A/S Pth compounds with low peak-to-trough ratios
MA46428B1 (fr) 2016-09-29 2025-02-28 Ascendis Pharma Bone Diseases A/S Composés de pth à libération contrôlée
ES2981967T3 (es) 2017-01-05 2024-10-14 Radius Pharmaceuticals Inc Formas polimórficas de RAD1901-2HCl
WO2019059302A1 (ja) * 2017-09-22 2019-03-28 旭化成ファーマ株式会社 安定性に優れるテリパラチド含有液状医薬組成物
WO2020010216A1 (en) 2018-07-04 2020-01-09 Radius Pharmaceuticals, Inc. Polymorphic forms of rad 1901-2hcl
EP3829625A4 (en) * 2018-07-30 2022-08-10 Shire-NPS Pharmaceuticals, Inc. FORMULATIONS TO IMPROVE THE STABILITY OF RECOMBINANT HUMAN PARATHYROID HORMONE
MX2021009370A (es) 2019-02-11 2021-09-10 Ascendis Pharma Bone Diseases As Formulaciones farmaceuticas liquidas de conjugados de hormona paratiroidea.
PH12021551950A1 (en) 2019-02-12 2022-05-23 Radius Pharmaceuticals Inc Processes and compounds
CN112439054B (zh) * 2019-08-28 2023-05-16 深圳翰宇药业股份有限公司 一种特立帕肽缓释凝胶注射液及其制备方法
JP7557544B2 (ja) * 2020-03-30 2024-09-27 スーチュワン ルーチョウ ブーチャン バイオ－ファーマシューティカル カンパニー リミテッド ヒト副甲状腺ホルモン（ｐｔｈ）の製剤及びそれを生成する方法
CN113101275A (zh) * 2021-05-27 2021-07-13 海南通用康力制药有限公司 注射用棓丙酯冻干粉针剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0643981B1 (en) * 1993-09-22 2002-01-09 Hisamitsu Pharmaceutical Co., Inc. A matrix for iontophoreses
ZA966075B (en) * 1995-07-27 1998-01-19 Genentech Inc Protein formulation.
JP4607010B2 (ja) * 2003-02-28 2011-01-05 中外製薬株式会社 タンパク質含有安定化製剤
KR20070010115A (ko) * 2003-11-13 2007-01-22 알자 코포레이션 경피전달용 조성물 및 장치
WO2007044375A2 (en) * 2005-10-06 2007-04-19 Nastech Pharmaceutical Company Inc. Pth formulations and methods of use
AU2006299887A1 (en) * 2005-10-06 2007-04-19 Nastech Pharmaceutical Company Inc. PTH formulations and methods of use
US8093207B2 (en) * 2005-12-09 2012-01-10 Unigene Laboratories, Inc. Fast-acting oral peptide pharmaceutical products

Also Published As

Publication number Publication date
SI2219665T1 (sl) 2011-09-30
WO2009053106A1 (en) 2009-04-30
ATE501725T1 (de) 2011-04-15
HRP20110444T1 (hr) 2011-08-31
HK1146465A1 (en) 2011-06-10
EP2219665A1 (en) 2010-08-25
EP2052736A1 (en) 2009-04-29
ES2363272T3 (es) 2011-07-28
RU2010121165A (ru) 2011-12-10
RU2467762C2 (ru) 2012-11-27
DE602008005643D1 (de) 2011-04-28
EP2219665B1 (en) 2011-03-16
CY1112106T1 (el) 2015-11-04
PT2219665E (pt) 2011-06-29
ZA201002812B (en) 2011-12-28
DK2219665T3 (da) 2011-06-27
PL2219665T3 (pl) 2011-11-30

Similar Documents

Publication Publication Date Title
MX2010004388A (es) Formulaciones de hormona paratiroidea y usos de las mismas.
HRP20060147B1 (hr) Terapijski sustav s kontroliranim otpuštanjem za nazalnu primjenu
MX2011009174A (es) Formulaciones de insulina para captacion rapida.
IL190838A0 (en) Intranasal administration of rapid acting insulin
TW200640497A (en) Pharmaceutical formulations and methods of use
TNSN08061A1 (en) Liquid formulations
AR049084A1 (es) Composiciones de cuidado personal y concentrados para su elaboracion
WO2009048945A8 (en) Rapid mucosal gel or film insulin compositions
AR059350A1 (es) Formulacion farmaceutica para aerosoles con dos o mas principios activos y al menos una sustancia tensioactiva
CO6361907A2 (es) Suministro transdermico de farmaco empleando un osmolito y un agente vasoactivo
BR112014019262A8 (pt) Composições orais veterinárias parasíticas compreendendo ingredientes ativos de ação sistêmica, métodos e uso das mesmas
PL2381925T3 (pl) Kompozycje pianotwórcze do leczenia skóry ludzkiej zasadniczo niezawierające aktywnych składników farmaceutycznych
IN2014MN01470A (es)
UA105496C2 (uk) Доставка октреотиду сухими фармакологічними формами
WO2014096985A3 (en) A stable aqueous composition comprising human insulin or an analogue or derivative thereof
GT200600431A (es) Formulacion acuosa hfsh
MX2014008283A (es) Formulacion de liberacion prolongada para reducir la frecuencia de orinar y metodos de uso de esta.
MX341660B (es) Agonista del receptor de ghrelina para el tratamiento de caquexia.
TR200806300A2 (tr) Çözünürlük artırıcı farmasötlk formulasyon
BRPI0921835A2 (pt) formulação única para administrar ao canal de teta da glândula mamária de um animal e uso da formulação na manufatura de um medicamento.
EP2090299A3 (en) Extended Release Gliclazide Formulations
TR200806302A2 (tr) Çözünürlük ve stabilite artırıcı farmasötik formülasyon.
AR063816A1 (es) Composicion farmaceutica que comprende ciclobenzaprina y aceclofenac en asociacion
UY27472A1 (es) Metodo para la preparación de una composición farmacéutica que comprende un acido-5-amino-salicilico, para uso en el tratamiento de la colitis ulcerosa y enfermedad de crohn.
TR200806303A2 (tr) Çözünürlük ve stabililte artırıcı farmasötik formülasyon

Legal Events

Date Code Title Description
FG Grant or registration
HC Change of company name or juridical status